Fact CheckerSign in

NCT04126369Recruiting

Impact of Mindfulness Intervention on Quality of Life in Patients With Drug-resistant Epilepsy.

Source: ClinicalTrials.gov · Last updated 8 May 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study evaluates a mindfulness intervention in patients with drug resistant epilepsy. Half of participants will follow a mindfulness programme, while the other half will follow a self management programme.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
2 Aug 2019
Start date
20 Jan 2020
Primary completion date
20 Jan 2026
Lead sponsor
University Hospital, Grenoble
Diseases
Epilepsy
NCT number
NCT04126369

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 20 Jan 2020 to the primary completion date, 20 Jan 2026
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patient who has previously had or regularly practicing mindfulness

Other illness

  • Patient with psychogenic non-epileptic seizures
  • Patient with relationship disorders related to psychosis

Other

  • Pregnant woman, breastfeeding mother, person deprived of liberty by judicial or administrative decision, person subject to legal protection
  • Patients who are unable or unwilling to work as a group or person unable to understand the topics discussed during session.

Who the study is looking for

  • Drug resistant epilepsy according to the criteria of the International League Against Epilepsy (ILAE)
  • Stable therapy for at least 3 months
  • No planned surgery
  • Patient affiliated to social security insurance or beneficiary of social security insurance.
  • Signed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Epileptology Department of The Grenoble University Hospital
Coordinator of this site? Confirm its status
GrenobleFranceRecruiting
Epileptology Department of the Lyon University Hospital
Coordinator of this site? Confirm its status
LyonFranceNot yet recruiting
La Teppe medical centre
Coordinator of this site? Confirm its status
Tain-l'HermitageFranceNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.